US Stock MarketDetailed Quotes

VOR Vor Biopharma

Watchlist
  • 0.867
  • -0.019-2.19%
Close Dec 20 16:00 ET
  • 0.900
  • +0.033+3.77%
Post 20:01 ET
59.56MMarket Cap-0.53P/E (TTM)

Vor Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
16.54%-23.29M
9.35%-21.85M
-25.54%-30.47M
-17.79%-100.29M
-30.96%-24.03M
-47.59%-27.9M
3.57%-24.1M
-5.96%-24.27M
-23.14%-85.14M
-4.32%-18.35M
Net income from continuing operations
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-33.67%-92.09M
-31.00%-23.91M
Depreciation and amortization
-4.70%851K
-0.11%869K
12.66%943K
38.30%3.49M
41.14%892K
313.13%893K
-53.87%870K
96.48%837K
76.08%2.53M
60.00%632K
Other non cash items
105.33%132K
6.20%1.25M
8.17%1.23M
32.11%4.73M
407.05%4.89M
---2.48M
--1.18M
23.80%1.14M
12.13%3.58M
7.95%964K
Change In working capital
-107.81%-99K
68.02%1.41M
-508.57%-4.12M
106.61%650K
-871.29%-779K
344.79%1.27M
113.75%838K
79.63%-677K
-7.09%-9.84M
105.53%101K
-Change in prepaid assets
-149.13%-169K
-99.09%20K
-10,242.86%-710K
1,353.33%3.27M
882.42%712K
-67.05%344K
118.08%2.21M
100.40%7K
103.54%225K
88.98%-91K
-Change in payables and accrued expense
-81.76%485K
414.95%551K
-2,720.45%-2.48M
155.83%2.85M
-89.61%172K
185.61%2.66M
114.25%107K
87.81%-88K
175.06%1.11M
2,200.00%1.66M
-Change in other current assets
167.36%551K
468.13%1.76M
-105.22%-7K
-161.72%-1.89M
-1,444.68%-726K
-65.92%-818K
-936.96%-477K
199.26%134K
-7.93%-721K
86.69%-47K
-Change in other current liabilities
-5.34%-966K
8.01%-919K
-26.16%-921K
65.73%-3.58M
33.87%-937K
54.15%-917K
84.17%-999K
-0.41%-730K
-308.52%-10.45M
-97.08%-1.42M
Cash from discontinued investing activities
Operating cash flow
16.54%-23.29M
9.35%-21.85M
-25.54%-30.47M
-17.79%-100.29M
-30.96%-24.03M
-47.59%-27.9M
3.57%-24.1M
-5.96%-24.27M
-23.14%-85.14M
-4.32%-18.35M
Investing cash flow
Cash flow from continuing investing activities
-100.08%-34K
288.52%52.99M
576.72%43.97M
175.47%71.01M
110.65%10.34M
219.13%40.54M
604.77%13.64M
192.10%6.5M
-2.66%-94.09M
-1,530.04%-97.04M
Net PPE purchase and sale
92.69%-34K
97.74%-9K
-21.28%-114K
87.37%-1.07M
65.42%-111K
-56.04%-465K
93.16%-399K
95.33%-94K
-117.31%-8.46M
72.52%-321K
Net investment purchase and sale
--0
277.54%53M
568.80%44.09M
184.17%72.08M
110.80%10.45M
215.39%41M
348.50%14.04M
230.69%6.59M
2.42%-85.63M
-1,921.21%-96.72M
Cash from discontinued investing activities
Investing cash flow
-100.08%-34K
288.52%52.99M
576.72%43.97M
175.47%71.01M
110.65%10.34M
219.13%40.54M
604.77%13.64M
192.10%6.5M
-2.66%-94.09M
-1,530.04%-97.04M
Financing cash flow
Cash flow from continuing financing activities
-76.70%41K
-114.22%-31K
-96.19%96K
-97.49%2.94M
-99.98%25K
-95.68%176K
-63.91%218K
1,159.50%2.52M
-49.71%117.14M
36,467.10%112.26M
Net common stock issuance
-71.68%111K
-115.89%-92K
-92.32%278K
-96.05%4.58M
-100.01%-15K
-89.79%392K
14.88%579K
--3.62M
-38.70%115.98M
11,163,100.00%111.63M
Proceeds from stock option exercised by employees
67.59%-70K
116.90%61K
52.85%-182K
-179.23%-923K
-93.66%40K
-192.31%-216K
-461.00%-361K
-293.00%-386K
110.67%1.17M
104.87%631K
Net other financing activities
----
----
----
---717K
--0
--0
--0
---717K
----
----
Cash from discontinued financing activities
Financing cash flow
-76.70%41K
-114.22%-31K
-96.19%96K
-97.49%2.94M
-99.98%25K
-95.68%176K
-63.91%218K
1,159.50%2.52M
-49.71%117.14M
36,467.10%112.26M
Net cash flow
Beginning cash position
126.68%78.49M
5.59%47.38M
-43.82%33.77M
-50.81%60.12M
-24.99%47.44M
-47.03%34.63M
--44.87M
-50.81%60.12M
143.95%122.21M
-56.52%63.24M
Current changes in cash
-281.66%-23.28M
403.74%31.11M
189.20%13.6M
57.57%-26.35M
-337.87%-13.67M
703.01%12.81M
---10.24M
---15.25M
-186.10%-62.1M
86.57%-3.12M
End cash Position
16.38%55.21M
126.68%78.49M
5.59%47.38M
-43.82%33.77M
-43.82%33.77M
-24.99%47.44M
--34.63M
--44.87M
-50.81%60.12M
-50.81%60.12M
Free cash flow
17.78%-23.32M
10.79%-21.86M
-25.52%-30.58M
-8.28%-101.36M
-29.30%-24.14M
-47.72%-28.36M
20.52%-24.5M
2.22%-24.36M
-28.16%-93.61M
0.47%-18.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 16.54%-23.29M9.35%-21.85M-25.54%-30.47M-17.79%-100.29M-30.96%-24.03M-47.59%-27.9M3.57%-24.1M-5.96%-24.27M-23.14%-85.14M-4.32%-18.35M
Net income from continuing operations 16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-33.67%-92.09M-31.00%-23.91M
Depreciation and amortization -4.70%851K-0.11%869K12.66%943K38.30%3.49M41.14%892K313.13%893K-53.87%870K96.48%837K76.08%2.53M60.00%632K
Other non cash items 105.33%132K6.20%1.25M8.17%1.23M32.11%4.73M407.05%4.89M---2.48M--1.18M23.80%1.14M12.13%3.58M7.95%964K
Change In working capital -107.81%-99K68.02%1.41M-508.57%-4.12M106.61%650K-871.29%-779K344.79%1.27M113.75%838K79.63%-677K-7.09%-9.84M105.53%101K
-Change in prepaid assets -149.13%-169K-99.09%20K-10,242.86%-710K1,353.33%3.27M882.42%712K-67.05%344K118.08%2.21M100.40%7K103.54%225K88.98%-91K
-Change in payables and accrued expense -81.76%485K414.95%551K-2,720.45%-2.48M155.83%2.85M-89.61%172K185.61%2.66M114.25%107K87.81%-88K175.06%1.11M2,200.00%1.66M
-Change in other current assets 167.36%551K468.13%1.76M-105.22%-7K-161.72%-1.89M-1,444.68%-726K-65.92%-818K-936.96%-477K199.26%134K-7.93%-721K86.69%-47K
-Change in other current liabilities -5.34%-966K8.01%-919K-26.16%-921K65.73%-3.58M33.87%-937K54.15%-917K84.17%-999K-0.41%-730K-308.52%-10.45M-97.08%-1.42M
Cash from discontinued investing activities
Operating cash flow 16.54%-23.29M9.35%-21.85M-25.54%-30.47M-17.79%-100.29M-30.96%-24.03M-47.59%-27.9M3.57%-24.1M-5.96%-24.27M-23.14%-85.14M-4.32%-18.35M
Investing cash flow
Cash flow from continuing investing activities -100.08%-34K288.52%52.99M576.72%43.97M175.47%71.01M110.65%10.34M219.13%40.54M604.77%13.64M192.10%6.5M-2.66%-94.09M-1,530.04%-97.04M
Net PPE purchase and sale 92.69%-34K97.74%-9K-21.28%-114K87.37%-1.07M65.42%-111K-56.04%-465K93.16%-399K95.33%-94K-117.31%-8.46M72.52%-321K
Net investment purchase and sale --0277.54%53M568.80%44.09M184.17%72.08M110.80%10.45M215.39%41M348.50%14.04M230.69%6.59M2.42%-85.63M-1,921.21%-96.72M
Cash from discontinued investing activities
Investing cash flow -100.08%-34K288.52%52.99M576.72%43.97M175.47%71.01M110.65%10.34M219.13%40.54M604.77%13.64M192.10%6.5M-2.66%-94.09M-1,530.04%-97.04M
Financing cash flow
Cash flow from continuing financing activities -76.70%41K-114.22%-31K-96.19%96K-97.49%2.94M-99.98%25K-95.68%176K-63.91%218K1,159.50%2.52M-49.71%117.14M36,467.10%112.26M
Net common stock issuance -71.68%111K-115.89%-92K-92.32%278K-96.05%4.58M-100.01%-15K-89.79%392K14.88%579K--3.62M-38.70%115.98M11,163,100.00%111.63M
Proceeds from stock option exercised by employees 67.59%-70K116.90%61K52.85%-182K-179.23%-923K-93.66%40K-192.31%-216K-461.00%-361K-293.00%-386K110.67%1.17M104.87%631K
Net other financing activities ---------------717K--0--0--0---717K--------
Cash from discontinued financing activities
Financing cash flow -76.70%41K-114.22%-31K-96.19%96K-97.49%2.94M-99.98%25K-95.68%176K-63.91%218K1,159.50%2.52M-49.71%117.14M36,467.10%112.26M
Net cash flow
Beginning cash position 126.68%78.49M5.59%47.38M-43.82%33.77M-50.81%60.12M-24.99%47.44M-47.03%34.63M--44.87M-50.81%60.12M143.95%122.21M-56.52%63.24M
Current changes in cash -281.66%-23.28M403.74%31.11M189.20%13.6M57.57%-26.35M-337.87%-13.67M703.01%12.81M---10.24M---15.25M-186.10%-62.1M86.57%-3.12M
End cash Position 16.38%55.21M126.68%78.49M5.59%47.38M-43.82%33.77M-43.82%33.77M-24.99%47.44M--34.63M--44.87M-50.81%60.12M-50.81%60.12M
Free cash flow 17.78%-23.32M10.79%-21.86M-25.52%-30.58M-8.28%-101.36M-29.30%-24.14M-47.72%-28.36M20.52%-24.5M2.22%-24.36M-28.16%-93.61M0.47%-18.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Alphabet-C
GOOG
+1.72%

Unlock the Full List